RxDoctor Payments Data

Steven Tooze, MD

Orthopaedic Surgery · Dover, DENPI 1427051226

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Pacira Therapeutics, Inc. at 54.2% of the total. Reporting peaked in 2019 at $362 and has fallen 67.6% since, to $117 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in DE, where the typical reported total is $6,222.

$1,161in general payments, 2019–2025

Across 39 payments — averaging $29.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Therapeutics, Inc.$629
  • Johnson & Johnson$101
  • Boston Scientific$68
  • Smith+Nephew$57
  • Pacira Pharmaceuticals Incorporated$44
  • Heron Therapeutics, Inc.$39
  • plus $224 from 11 others

What the payments were for

  • Food & beverage$1,161100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,161 in reported general payments places this provider in the 25th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$551,009
Medicare patients
1,306
Services billed
9,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib57$1,122
Oxycodone Hcl75$415
Diclofenac Sodium13$266
Gabapentin34$258
Meloxicam23$255
Prochlorperazine Maleate25$238
Cephalexin17$230
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$175
Cyclobenzaprine Hcl15$130
Amoxicillin51$104
Tramadol Hcl18$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →